Top Ad

Colistin (Polymyxin E)

Form: Injectable (IV/IM/SC)

Strength: 150 mg/5 mL, 300 mg/5 mL, 1.5 million IU/vial

Reference Brands: Coly-Mycin M(US)

Category: Antibiotics

Colistin (Polymyxin E) is approved in the EU and US for severe, multidrug-resistant Gram-negative bacterial infections. In the EU, brands like Colistin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans for approval and safety monitoring. Due to its critical role in combating resistant infections, strict prescribing, storage, and administration regulations are enforced. For regulatory support, dossier preparation, and compliance, visit PharmaTradz. We support seamless market access while ensuring adherence to European and US standards.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Colistin (Polymyxin E) Inhalation Solution (Nebulizer)

Strength: 75 mg/2 mL

Form: Inhalation Solution (Nebulizer)

Reference Brands: Coly-Mycin M(US)

View More Get Enquiry
Fosfomycin Oral Sachets or Powder for Suspension

Strength: 3g in a sachet

Form: Oral Sachets or Powder for Suspension

Reference Brands: Zyflo(US)

View More Get Enquiry
Fosfomycin IV

Strength: 2 g, 4g per vial

Form: Intravenous (IV)

Reference Brands: Zyflo(US)

View More Get Enquiry
Teicoplanin Injectable (IV/IM)

Strength: 200 mg/100 mL, 400 mg/200 mL, 400 mg/100 mL

Form: Injectable (IV/IM)

Reference Brands: Targocid, Tolocin(US & EU)

View More Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.